Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Cardiac Output, Low (Phase 3)
Cognition (Phase 2)
Critical Illness (Phase 2)
Dementia (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Diet (Phase 1)
Dietary Supplements (Phase 1)
Drug Resistant Epilepsy (Phase 2/Phase 3)
Exercise (Phase 2)
Healthy Volunteers (Phase 2)
Heart Failure (Phase 3)
Heart Failure, Diastolic (Phase 2)
Heart Failure, Systolic (Early Phase 1)
Hemodynamics (Phase 3)
Intensive Care Units (Phase 2)
Ketones (Phase 1)
Ketosis (Phase 3)
Muscle, Skeletal (Phase 2)
Placebos (Phase 1)
Polycystic Kidney, Autosomal Dominant (Phase 2)
Running (Phase 2)
Sleep (Phase 2)
Status Epilepticus (Phase 2/Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue